Manufacturers should not wait for final HTA scopes to test whether their evidence package can addres...
The first EU Joint Clinical Assessments (JCAs) are now providing real-world evidence of how the new ...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.